Feasibility Study of Telerehabilitation for People with Chronic Obstructive Pulmonary Disease in Nuuk

Steno Diabetes Center Greenland

Status: Not yet enrolling

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Study type: Observational

Funder types: Other

Identifiers

NCT06660589

2024-20410

NNF20SA0064190 (Other Grant/Funding Number)

Details and patient eligibility

About

Chronic obstructive pulmonary disease, or COPD, is a major global health issue. It can make people ill, impact their quality of life, and increase their use of healthcare services. In some parts of Greenland, it can be particularly challenging to manage COPD due to the distance to healthcare assistants, nurses, or doctors. Telerehabilitation, which allows people to receive treatment online, could be a good solution.

This project aims to explore how we can best support COPD patients in Nuuk through an online rehabilitation program. The program functions as a pilot study, where we examine how it can be adapted and scaled across Greenland and to patients with other conditions. We will assess how well the program meets patients' needs and determine what adjustments are necessary to improve it.

The study will include 10 individuals with COPD living in Nuuk. They will receive training materials and have an initial meeting with a physiotherapist to set goals. For 10 weeks, they will participate in online training sessions twice a week. Through their feedback, we hope to identify ways to make the program more effective and tailored.

Before the training program begins, participants will have various health metrics measured, complete a questionnaire, and perform a physical test. This will be repeated after the training program is completed to assess any changes in the participants.

We hope that the results will provide insights into improving the treatment of COPD patients and guide necessary adjustments for future rollout across Greenland and to other disease groups. All participants will provide consent for their involvement, and their data will be treated anonymously.

Full description

In this study, data will be collected at multiple time points relative to when participants are enrolled:

• Baseline data collection occurs before the intervention begins. Participants will undergo an initial consultation via PUISA, where various assessments (such as the Sit-to-Stand test, CAT score, MRC score, and other health measurements) will be performed. Additionally, participants will fill out a questionnaire and have their physical condition tested.
• Post-intervention data collection occurs after the 10-week training program has concluded. During this final evaluation, the same parameters assessed at baseline (physical condition, CAT questionnaire, etc.) will be measured again. Participants will also provide feedback through qualitative interviews, focusing on their experiences with the program.

Thus, data will be collected both before (pre-intervention) and after (post-intervention) the 10-week telerehabilitation program to evaluate changes and gather feedback.

Sampling method:

The study will employ purposive sampling to select participants who meet specific criteria, such as having a certain level of illness or the ability to participate in a telerehabilitation program. Sampling will be conducted based on age, sex, and degree of illness to ensure a well-defined and relevant participant group.

Enrollment: 10 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Residing in Nuuk
• Has access to a computer/phone and the internet
• Understands Danish and can participate in a Danish dialogue
• Motivated to participate in online training
• Post-bronchodilator FEV1/FVC ratio below 0.7, and FEV1 below 80% of predicted value
• MRC score of 2 or higher

Exclusion criteria

• Unstable angina pectoris
• Hemodynamically significant aortic stenosis
• Physical or psychological condition that prevents benefit from a video consultation, e.g., deafness, muteness, or blindness
• Exacerbation within 6 weeks, lung infection, or other factors that affect the results of a lung function test

Trial design

10 participants in 1 patient group

People with COPD

Description:

People with COPD